Investigation of the genetic architecture and phenotypic spectrum of Bosma arhinia microphthalmia syndrome
$1,639,369ZIAFY2019ESNIH
National Institute Of Environmental Health Sciences
Investigators
Linked publications & trials
Paper 36800423Paper 35121673Paper 32034419Paper 31420322Paper 31312724Paper 31243061Paper 31132118Paper 29980640Paper 28546579
Abstract
Through an international consortium, we have established a cohort of nearly 50 patients with arhinia and arhinia sub-phenotypes as well as their family members. All patients have undergone whole-exome or targeted sequencing of SMCHD1, with rare, heterozygous missense mutations (in exons 3-13) identified in approximately 90%. Eight patients have undergone deep phenotyping studies that include reproductive, neuromuscular, ophthalmologic, olfactory, and craniofacial assessments at the NIH Clinical Center. Nine patients have undergone skin punch biopsies to provide fibroblasts for iPSC-based experiments.
View original record on NIH RePORTER →